Clinical and economic burden of Clostridium difficile infection in Europe: A systematic review of healthcare-facility-acquired infection

Journal of Hospital Infection

Volumn 81, Issue 1, 2012, Pages 1-14

  Wiegand, P N ^a   Nathwani, D ^b   Wilcox, M H ^c   Stephens, J ^a   Shelbaya, A ^d   Haider, S ^d  

^a PHARMERIT INTERNATIONAL   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^d PFIZER INC   (United States)

Author keywords

Burden; Clostridium difficile; Cost; Europe; Healthcare facilities; Hospital; Hospital acquired; Length of stay; Mortality; Nosocomial; Recurrence; Review

Indexed keywords

CLOSTRIDIUM DIFFICILE INFECTION; EUROPE; HEALTH CARE COST; HEALTH SURVEY; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; MORTALITY; PUBLIC HEALTH PROBLEM; RECURRENT DISEASE; REVIEW; SYSTEMATIC REVIEW;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; EUROPE; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY; PREVALENCE; SURVIVAL ANALYSIS;

EID: 84860348952     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.02.004     Document Type: Review

References (88)

1. Gerding D.N. Global epidemiology of Clostridium difficile infection in 2010. Infect Control Hosp Epidemiol 2010, 31(Suppl. 1):S32-S34.
2. Bauer M.P., Notermans D.W., van Benthem B.H., et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377:63-73.
3. Health Protection Agency, Department of Health. Clostridium difficile infection: how to deal with the problem 2008, Department of Health, London, p. 42-50.
4. Kuijper E.J., Barbut F., Brazier J.S., et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 2008, 13:1-10.
5. Dubberke E.R., Wertheimer A.I. Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol 2009, 30:57-66.
6. Al-Eidan F.A., McElnay J.C., Scott M.G., Kearney M.P. Clostridium difficile-associated diarrhoea in hospitalised patients. J Clin Pharm Ther 2000, 25:101-109.
7. Vonberg R.P., Reichardt C., Behnke M., Schwab F., Zindler S., Gastmeier P. Costs of nosocomial Clostridium difficile-associated diarrhoea. J Hosp Infect 2008, 70:15-20.
8. Wilcox M.H., Cunniffe J.G., Trundle C., Redpath C. Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 1996, 34:23-30.
9. McGlone S.M., Bailey R.R., Zimmer S.M., et al. The economic burden of Clostridium difficile. Clin Microbiol Infect 2011, 18:282-289.
10. Higgins J, Green S, editors. General methods for Cochrane reviews. Cochrane handbook for systematic reviews of interventions. Version 5.0.2. Oxford: The Cochrane Collaboration; 2011.
11. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097.
12. Curtis L, editor. Inflation indices. Unit costs of health and social care. Canterbury Personal Social Services Research Unit; 2010.
13. Eurostat. European Commission consumer prices (consumer price health index, monthly). In: Harmonized indices of consumer prices. Luxembourg City: Luxembourg Office of Official Publications of the European Communities; 2012.
14. Coignard B, Hebert M, Eckert C, et al. Epidemiological and microbiological characteristics of Clostridium difficile infections, France, 2009: a national, multicentre, prospective survey. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria; 10-13 April 2010.
15. Pockett RD. Clostridium difficile 027: prevalence and severity in a single centre in the United Kingdom (UK). 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA USA; 12-15 September 2010.
16. Gorschluter M., Glasmacher A., Hahn C., et al. Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 2001, 33:786-791.
17. Indra A., Schmid D., Huhulescu S., et al. Characterization of clinical Clostridium difficile isolates by PCR ribotyping and detection of toxin genes in Austria, 2006-2007. J Med Microbiol 2008, 57:702-708.
18. Lyytikainen O., Turunen H., Sund R., et al. Hospitalizations and deaths associated with Clostridium difficile infection, Finland, 1996-2004. Emerg Infect Dis 2009, 15:761-765.
19. Arvand M., Hauri A.M., Zaiss N.H., Witte W., Bettge-Weller G. Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany. Euro Surveill 2009, 14:19403.
20. Hardt C., Berns T., Treder W., Dumoulin F.L. Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein. World J Gastroenterol 2008, 14:4338-4341.
21. Drudy D., Harnedy N., Fanning S., Hannan M., Kyne L. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infect Control Hosp Epidemiol 2007, 28:932-940.
22. Mossong J, Reichert P, Munisso F, Sertznig M, Even J, Schneider F. Microbiological surveillance of Clostridium difficile infections in Luxembourg, 2006-2007. 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain; 19-22 April 2008.
23. Gudiol C, Garcia-Vidal C, Niubo J, Duarte R, Jimenez L, Carratala J. Clostridium difficile-associated diarrhoea in immunosuppressed patients with cancer. 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland; 16-19 May 2009.
24. Kasper S, Kanitz EE, Indra A, et al. A Clostridium difficile 027 epidemic in a hospital in Vienna, Austria, 2008-2009. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria; 10-13 April 2010.
25. Maujean G, Brulet A, Girard M, et al. Factors associated with the severity of Clostridium difficile-associated disease: a one-year prospective study in a Lyon university hospital, France. 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain; 19-22 April 2008.
26. Bacci S, Olsen KE, Jensen JN, Molbak K. Higher mortality of Clostridium difficile possessing the genes for the binary toxin in addition to the genes for toxin A and toxin B. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria; 10-13 April 2010.
27. Fenner L., Frei R., Gregory M., Dangel M., Stranden A., Widmer A.F. Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006-2007. Eur J Clin Microbiol Infect Dis 2008, 27:1201-1207.
28. Gulihar A., Nixon M., Jenkins D., Taylor G.J.S. Clostridium difficile in hip fracture patients: prevention, treatment and associated mortality. Injury 2009, 40:746-751.
29. Hawkyard C., Bignardi G.E. Has the severity of Clostridium difficile infections increased?. J Hosp Infect 2006, 63:111-112.
30. Morgan O.W., Rodrigues B., Elston T., et al. Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS ONE 2008, 3:e1812.
31. Shears P., Prtak L., Duckworth R. Hospital-based epidemiology: a strategy for 'dealing with Clostridium difficile'. J Hosp Infect 2010, 74:319-325.
32. Sundram F., Guyot A., Carboo I., Green S., Lilaonitkul M., Scourfield A. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors. J Hosp Infect 2009, 72:111-118.
33. Wilson V., Cheek L., Satta G., et al. Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis 2010, 50:e77-e81.
34. Soler P., Nogareda F., Cano R. Rates of Clostridium difficile infection in patients discharged from Spanish hospitals, 1997-2005. Infect Control Hosp Epidemiol 2008, 29:887-889.
35. Jen M.H., Holmes A.H., Bottle A., Aylin P. Descriptive study of selected healthcare-associated infections using national Hospital Episode Statistics data 1996-2006 and comparison with mandatory reporting systems. J Hosp Infect 2008, 70:321-327.
36. Bossuyt P., Verhaegen J., Van Assche G., Rutgeerts P., Vermeire S. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohns Colitis 2009, 3:4-7.
37. Elumogo N, Hegarty T, Vautier G, et al. Is Clostridium difficile 027 more virulent than other ribotypes? Report of the first outbreak of Clostridium difficile ribotype 027 in East of England: correlation of outbreak and non-outbreak ribotypes with severity of disease. 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland; 16-19 May 2009.
38. Rodrigues M.A., Brady R.R., Rodrigues J., Graham C., Gibb A.P. Clostridium difficile infection in general surgery patients; identification of high-risk populations. Int J Surg 2010, 8:368-372.
39. Hell M, Greil R, Berr F, et al. Clinical-epidemiological characterisation of Clostridium difficile - ribotype 053. 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain; 19-22 April 2008.
40. Coignard B, Barbut F, Blanckaert K, et al. Emergence of PCR-ribotype 027 Clostridium difficile-associated disease, Northern France, 2006. 17th European Congress of Clinical Microbiology and Infectious Diseases, Munich, Germany; 31 March-3 April 2007.
41. Staub T, Sakka C, Arendt V, et al. Outbreak of Clostridium difficile-associated disease in Luxembourg. 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain; 19-22 April 2008.
42. Vicente MR, Pariente M, Riquelme E, Sainz de Baranda C, Martinez M, Crespo MD. Clostridium difficile-associated diseases: a 2-year study. 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain; 19-22 April 2008.
43. Guleri A, Sharma R, Palmer R, Huda T, Ambalkar S, Luxton P. First patient-centred, multidisciplinary clinical audit in hospital/community, study of risk factors, clinical outcomes and patient perspectives of Clostridium difficile-associated diarrhoea. 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain; 19-22 April 2008.
44. Ang C.W., Heyes G., Morrison P., Carr B. The acquisition and outcome of ICU-acquired Clostridium difficile infection in a single centre in the UK. J Infect 2008, 57:435-440.
45. Goorhuis A., Bakker D., Corver J., et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008, 47:1162-1170.
46. Mitu-Pretorian O.M., Forgacs B., Qumruddin A., Tavakoli A., Augustine T., Pararajasingam R. Outcomes of patients who develop symptomatic Clostridium difficile infection after solid organ transplantation. Transplant Proc 2010, 42:2631-2633.
47. Debast S.B., Vaessen N., Choudry A., Wiegers-Ligtvoet E.A., van den Berg R.J., Kuijper E.J. Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors. Clin Microbiol Infect 2009, 15:427-434.
48. Ben-Horin S., Margalit M., Bossuyt P., et al. Combination immunomodulatory and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection. Clin Gastroenterol Hepatol 2009, 7:981-987.
49. Eckmanns T. Mortality burden of Clostridium difficile-associated disease in adults: an under-recognized crisis. Clin Microbiol Infect 2010, 16:S123.
50. Goorhuis A, Debast SB, Dutilh JC, et al. A case-control study during an outbreak of Clostridium difficile infections due to PCR ribotypes 027 and 017 occurring simultaneously in one hospital in the Netherlands. 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland; 16-19 May 2009.
51. Goorhuis A. Outbreak with Clostridium difficile PCR-ribotypes 027 and 017 simultaneously in a Dutch hospital. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA USA; 12-15 September 2009.
52. Office for National Statistics Deaths involving Clostridium difficile: England and Wales, 1999-2009. Health Stat Quart 2010.
53. Gutierrez I, Lambert ML, Kongs A, Mazina D, van Oyen H. Trends in mortality due to Clostridium difficile enterocolitis in Brussels and Flanders, 1998-2006. 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland; 16-19 May 2009.
54. Cohen S.H., Gerding D.N., Johnson S., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
55. Bauer M.P., Kuijper E.J., van Dissel J.T. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 2009, 15:1067-1079.
56. Cheng A.C., Ferguson J.K., Richards M.J., et al. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection. Med J Aust 2011, 194:353-358.
57. Graf K., Cohrs A., Gastmeier P., et al. An outbreak of Clostridium difficile-associated disease (CDAD) in a German university hospital. Eur J Clin Microbiol Infect Dis 2009, 28:543-545.
58. Willems L. Risk factors and outcome of Clostridium difficile-associated disease after allogeneic stem cell transplantation. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA USA; 12-15 September 2009.
59. Lambert M.L., Mertens K., Ramboer I., Delmee M., Suetens C. Nation-wide prospective surveillance of Clostridium difficile infections in hospitals in Belgium, July 2007-June 2008. EuroSurveill 2009, 14:2-4.
60. Tangiisuran B., Davies J.G., Cheek L., Rajkumar C., Llewelyn M. Diagnosis of Clostridium difficile infection is associated with a small increased risk of death in elderly inpatients. J Hosp Infect 2010, 74:401-403.
61. Agthe N, Mattila E, Anttila VJ, Kanerva M. Resource use and costs associated with Clostridium difficile diarrhoea in a university hospital. 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland; 16-19 May 2009.
62. Debast SB, Vaessen N, Choudry A, van den Berg R, Kuijper EJ. Outbreak of Clostridium difficile PCR-ribotype 027 toxinotype III in Harderwijk, the Netherlands. 16th European Congress of Clinical Microbiology and Infectious Diseases, Nice, France; 1-4 April 2006.
63. Barbut F., Richard A., Hamadi K., Chomette V., Burghoffer B., Petit J.C. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000, 38:2386-2388.
64. Beaujean D., Blok H., Gigengack-Baars A., et al. Five-year surveillance of patients with communicable diseases nursed in isolation. J Hosp Infect 2001, 47:210-217.
65. Musa S.A., Robertshaw H., Thomson S.J., Cowan M.L., Rahman T.M. Clostridium difficile-associated disease acquired in the neurocritical care unit. Neurocritical Care 2010, 13:87-92.
66. Okoro C, O'Driscoll J, Smith A, Kirk A, Haworth E. The epidemiology of the second phase of a hospital outbreak of Clostridium difficile-associated diarrhoea, Stoke Mandeville, UK. 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain; 19-22 April 2008.
67. Reddy S., Taori S., Poxton I.R. Changes in laboratory and clinical workload for Clostridium difficile infection from 2003 to 2007 in hospitals in Edinburgh. Clin Microbiol Infect 2010, 16:340-346.
68. Nathwani D., Sneddon J., Malcolm W., et al. Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. Int J Antimicrob Agents 2011, 38:16-26.
69. Pepin J., Valiquette L., Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005, 173:1037-1042.
70. Beyersmann J., Kneib T., Schumacher M., Gastmeier P. Nosocomial infection, length of stay, and time-dependent bias. Infect Control Hosp Epidemiol 2009, 30:273-276.
71. Kyne L., Hamel M.B., Polavaram R., Kelly C.P. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002, 34:346-353.
72. Kutty P.K., Woods C.W., Sena A.C., et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis 2010, 16:197-204.
73. Freeman J., Bauer M.P., Baines S.D., et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010, 23:529-549.
74. Wilcox M.H., Mooney L., Bendall R., Settle C.D., Fawley W.N. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 2008, 62:388-396.
75. Wilcox M.H., Fawley W.N., Settle C.D., Davidson A. Recurrence of symptoms in Clostridium difficile infection - relapse or reinfection?. J Hosp Infect 1998, 38:93-100.
76. Indra A., Huhulescu S., Fiedler A., Kernbichler S., Blaschitz M., Allerberger F. Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008-2009. Euro Surveill 2009, 14:19186.
77. Kleinkauf N, Jansen A, Weiss B, Neumann M, Eckmanns T, Michels H. Detection of infections due to Clostridium difficile PCR ribotype 027 and implementation of a surveillance system for severe cases of Clostridium difficile-associated diarrhoea in Rhineland-Palatine, Germany, 2007. 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain; 19-22 April 2008.
78. Schalk E., Bohr U.R.M., Konig B., Scheinpflug K., Mohren M. Clostridium difficile-associated diarrhoea, a frequent complication in patients with acute myeloid leukaemia. Ann Hematol 2010, 89:9-14.
79. Aksenoka K, Goonewarden S, Pujate E, Balode A, Miklasevics E, Dumpis U. Surveillance of Clostridium difficile infection in Latvian multidisciplinary teaching hospital. 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain; 19-22 April 2008.
80. Paltansing S, Guseinova R, van den Berg R, Visser C, van der Vorm E, Kuijper EJ. National surveillance to the incidence of Clostridium difficile-associated diarrhoea in the Netherlands. 16th European Congress of Clinical Microbiology and Infectious Diseases, Nice, France; 1-4 April 2006.
81. Bentohami AA, Nolte CCM, Verberg CMF, et al. Succesful control of Clostridium difficile type 027 outbreak by cohort isolation of infected patients. 17th European Congress of Clinical Microbiology and Infectious Diseases, Munich, Germany; 31 March-3 April 2007.
82. Cleary P, Quigley C, O'Brien S, et al. A review of the epidemiology, risk factors and strain characteristics of Clostridium difficile among hospitalized patients: a pilot nested case-control study. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria; 10-13 April 2010.
83. Olesen B. A nosocomial outbreak of Clostridium difficile 027 north of Copenhagen. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA USA; 12-15 September 2009.
84. Burns K., Skally M., Solomon K., et al. Clostridium difficile infection in the Republic of Ireland: results of a 1-month national surveillance and ribotyping project, March 2009. Infect Control Hosp Epidemiol 2010, 31:1085-1087.
85. Goorhuis A., Van der Kooi T., Vaessen N., et al. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis 2007, 45:695-703.
86. Wultanska D., Banaszkiewicz A., Radzikowski A., et al. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease. Eur J Clin Microbiol Infect Dis 2010, 29:1265-1270.
87. Rodriguez D, Almirante R, Bartolome V, et al. Clostridium difficile-associated disease (CDAD): results from a population-based surveillance in Barcelona, Spain. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA USA; 12-15 September 2010.
88. Kato R, Maitland I, Ibeto M, Qulaghassi M Guleri A. Real-time monitoring and fine tuning of joint (PCT - acute hospital) Clostridium difficile infections containment programme: common root cause analysis of CDI in the community and hospital - the missing link. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria; 10-13 April 2010.